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Cystic ﬁbrosis (CF) lung disease is deﬁned by a continuous cycle of infection and
inﬂammation which has a deleterious effect on the quality of life and patient sur-
vival. Neutrophils and their derived products perpetuate the inﬂammation associated
with CF lung disease due to excessive inﬂammatory cytokines including TNF-a. A
potential therapeutic option for CF is the use of protease inhibitors such as alpha-1
antitrypsin (AAT), which is known to possess novel anti-inﬂammatory properties.
The aim of this study was to evaluate AAT potential to modulate neutrophil function
in response to the key inﬂammatory cytokine TNF-a.
An evaluation of AAT impact on the production of superoxide by TNF-a stimulated
neutrophils was carried out using a cytochrome C assay. The HL-60 cells were used
to determine AAT impact on TNF-a autocrine signaling through NF-úB activation,
assessed by western blot analysis of IúBa degradation and gene expression of
TNF-a. ELISA was employed to investigate the ability of AAT to inhibit TNF-a
binding to the TNF receptors TNF-R1 and TNF-R2.
Our results demonstrate that AAT reduced the production of superoxide in a dose
dependant manner in cells stimulated with TNF-a. AAT regulated TNF-a autocrine
signaling resulting in reduced IúBa degradation and subsequent TNF-a gene
expression in HL-60 cells. Protein binding studies conﬁrmed that AAT inhibition
of TNF-a signalling is in part due to AAT binding thereby preventing TNF-a
interaction with TNF Receptor 1 and Receptor 2 (p = 0.02).
This study has uncovered AAT as novel modulator of the TNF-a inﬂammatory
signaling pathway and highlights the potential for AAT as being a treatment option
for CF.
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In cystic ﬁbrosis (CF), neutrophils restrict bacterial infections to the airways,
however contribute to excessive airway tissue remodeling/destruction. Therefore,
reduction of neutrophils by anti-inﬂammatory drugs has been proposed. Whether
this negatively impacts innate immunity is unknown. We assessed the effects of
the orally administered leukotriene B4 (LTB4)-receptor antagonist BIIL 284 on
neutrophils, P. aeruginosa numbers and cytokines in C57Bl/6 mice. Treatment of
P. aeruginosa-infected mice with with 0.3, 50 or 100mg/kg body weight of BIIL 284
decreased pulmonary neutrophils signiﬁcantly after 24 h. While bacterial numbers
remained stable in total lung homogenates of animals treated with 0.3mg/kg
body weight of BIIL 284 after 24 h, P. aeruginosa cfus increased signiﬁcantly
(p< 0.01) when 50 or 100mg/kg body weight of BIIL 284 was administered
compared to untreated control animals. Signiﬁcantly higher bacteraemia rates and
lung inﬂammation were observed in BIIL 284 treated animals compared to placebo
treated animals. Because reduction of pulmonary neutrophils by BIIL 284 below
a critical level allows enhanced proliferation and transmission of pathogens to
the bloodstream in infected animals, care should be taken when administering
potent anti-inﬂammatory compounds in CF patients who already may suffer from
bacteraemia during acute exacerbation.
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Recently, several reports suggest that CFTR should contribute to altered inﬂam-
matory response in cystic ﬁbrosis (CF) by modiﬁcation of normal macrophage
functions. In order to highlight possible intrinsic macrophage defects due to CFTR
dysfunction, we have studied macrophages from human peripheral blood monocytes
of healthy subjects (non CF) and CF patients.
Ficoll isolated adherent monocytes were differentiated in macrophages with GM-
CSF (400U/mL) during 6 days. Non CF macrophages were treated during 72h with
CFTRinh−172 (10, 20 mM). We have focused to study some membrane markers of
CD71+ macrophages (mCD14, CD16, CD64, CD11b) by ﬂow cytometry. Soluble
CD14, IL-1b and IL-8 supernatant levels were quantiﬁed by ELISA. Phagocytosis
was measured by ﬂuorescein-labeled E. coli Bioparticles.
In CF macrophages, we have observed strong inhibition of phagocytosis (70%)
as well as 1.3-, 1.8- and 2.0-fold signiﬁcant decrease of CD16, CD64 and
CD11b respectively. However membrane CD14 (mCD14) was slightly increased but
mCD14/sCD14 ratio is in favor of sCD14 (1/6 vs 1/270 in CF cells). Elsewhere,
concentrations of IL-1b and IL-8 were strongly raised in CF cell supernatant. CFTR
inhibition in non CF macrophages also showed alterations in surface expression of
CD11b, CD16, CD64, IL-8 level and phagocytosis.
Pathogens recognition and phagocytosis seems to be impaired in CF macrophages,
and some alterations could be associated with CFTR defect. Thus, perturbations
of CD11b and sCD14, involved in innate immune response, may play a potential
important role in CF pathogenesis.
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Background: Oral treatment with egg yolk antibodies (IgY) against Pseudomonas
aeruginosa (PA) in cystic ﬁbrosis (CF) patients prevents PA infections in a clinical
study. IgY seems to acts as anti-adherence factor and bacterial neutralizer. The
present study evaluated the opsonizing capacity of IgY and polymorph neutrophils
(PMNs) burst and PMN mediated PA killing in vitro.
Methods: Anti-Pseudomonas speciﬁc (S-IgY) or non-speciﬁc (C-IgY) IgY anti-
bodies were obtained from ImmunSystem I.M.S. (Uppsala, Sweden).
PA vaccine-strains (PAO1, PAO3, PAO5, PAO6, PAO9, PAO11) and a ﬂagel mutant
strain were grown in LB broth.
PMNs were isolated from whole blood. The puriﬁed PMNs were resuspended in
Krebs-Ringer buffer with glucose and human sera at a density of 107 PMNs/ml.
Phagocytosis was commenced by adding 1×108 PA to PMNs with either C-IgY
or S-IgY. The phagocyte-derived reactive oxygen species (ROS) was measured
by adding luminol and using a luminometer. Mixing (non)opsonized bacteria and
PMNs and plating diluted samples overnight followed by colony counting evaluated
bacterial killing.
Results: S-IgY and C-IgY increased the chemiluminescense signal in all PA
vaccine-strains compared to non-IgY (p< 0.05). The S-IgY signal was higher than
C-IgY (p< 0.05) except in low concentration (0.005%). No difference between
S-IgY or C-IgY was observed in the ﬂagel mutant strain. Bacterial killing in +
SIgY groups ranged from 43%-97%, 21%-86% in + CIgY groups and 7%-72%
in non-IgY groups. S-IgY increased the bacterial killing in all the vaccine-strains
compared to non-IgY controls (p< 0.05).
Conclusions: Speciﬁc IgY opsonizes PA resulting in increased clearance by PMNs,
thus may explain the observed protective activity.
